Please assess the completion status of the following clinical trial:

Trial Title: Pravastatin Efficacy and Safety Trial in Hypercholesterolemic Patients With Chronic Liver Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Chronic, well-compensated stable liver~* Hypercholesterolemia~Exclusion Criteria:~* Signs or symptoms of ascites, jaundice, or cirrhosis with a Child-Pugh Score \> 5~* History of disorders affecting serum bilirubin levels, more than 1 chronic liver disease, significant endocrine, renal, or gastrointestinal disease, or uncontrolled hypertension~* Treatment with lipid-lowering drugs, unless they have been withdrawn within the timeframe specified in the protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).